Table 1.
Distribution of Aromatase Staining and Clinicopathological Factors in Invasive Breast Cancer
| Patient No. | Aromatase Staining
|
P Value | |||
|---|---|---|---|---|---|
| 0 | 1 | 2 | |||
| Age | |||||
| <50 yr | 53 | 12 (22) | 18 (34) | 23 (44) | 0.309 |
| >50 yr | 105 | 25 (24) | 24 (22) | 56 (54) | |
| Stage | |||||
| T1 (<20 mm) | 86 | 26 (30) | 27 (32) | 33 (39) | 0.005 |
| T2 (20–50 mm) | 72 | 11 (15) | 15 (21) | 46 (64) | |
| Grade | |||||
| 1 | 33 | 11 (33) | 8 (24) | 14 (42) | 0.667 |
| 2 | 97 | 20 (21) | 26 (27) | 51 (52) | |
| 3 | 28 | 6 (23) | 8 (27) | 14 (50) | |
| Case type | |||||
| Node negative | 52 | 24 (46) | 12 (23) | 16 (31) | 0.001 |
| Node positive | 53 | 6 (11) | 12 (23) | 35 (66) | |
| Metastatic disease | 53 | 7 (13) | 18 (34) | 28 (53) | |
| ER | |||||
| Positive | 102 | 24 (24) | 26 (26) | 52 (52) | 0.586 |
| Negative (unknown = 4) | 52 | 11 (21) | 16 (31) | 25 (48) | |
| PR | |||||
| Positive | 57 | 17 (31) | 12 (22) | 27 (48) | 0.496 |
| Negative (unknown = 2) | 99 | 20 (20) | 29 (29) | 50 (51) | |
| PELP1 | 0.008 | ||||
| 1 | 11 | 5 (45) | 1 (9) | 5 (46) | |
| 2 | 51 | 17 (33) | 17 (33) | 17 (33) | |
| 3 | 96 | 15 (16) | 24 (25) | 57 (60) | |